Literature DB >> 7923764

Free light chains of immunoglobulins: clinical laboratory analysis.

S S Levinson1, D F Keren.   

Abstract

The increased sensitivity of immunofixation electrophoresis (IFE) over prior electrophoretic methods has led to renewed interest in the study of free light chains. Here, we discuss problems associated with the identification of monoclonal free light chains (Bence Jones proteins) in urine. Besides reviewing the nature of the sample specimens and the assays themselves, we discuss the physiology, biochemistry, genetics, and immunological properties of these molecules. Direct measurement of kappa/lambda ratios may ultimately be useful, but all commercial methods available now lack sufficient sensitivity. IFE is the preferred method because of its sensitivity and ease of interpretation. There are, however, difficulties associated with the interpretation of urinary IFE patterns, because the technique does not include an intrinsic mechanism for antibody-antigen titration and because of its great sensitivity in the absence of quantification. Problems of interpretation are discussed.

Mesh:

Substances:

Year:  1994        PMID: 7923764

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.

Authors:  M Abe; T Goto; M Kosaka; D Wolfenbarger; D T Weiss; A Solomon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Monoclonal Light Chains Can Remain Unnoticed in Protein Electrophoresis.

Authors:  Hamit Yasar Ellidag; Esin Eren; Ozgur Aydin; Necat Yilmaz
Journal:  Indian J Clin Biochem       Date:  2015-02-28

3.  Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.

Authors:  Michelle M Sidor; Boris Sakic; Paul M Malinowski; David A Ballok; Curtis J Oleschuk; Joseph Macri
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

4.  Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.

Authors:  Thomas Dejoie; Jill Corre; Helene Caillon; Cyrille Hulin; Aurore Perrot; Denis Caillot; Eileen Boyle; Marie-Lorraine Chretien; Jean Fontan; Karim Belhadj; Sabine Brechignac; Olivier Decaux; Laurent Voillat; Philippe Rodon; Olivier Fitoussi; Carla Araujo; Lotfi Benboubker; Charlotte Fontan; Mourad Tiab; Pascal Godmer; Odile Luycx; Olivier Allangba; Jean-Michel Pignon; Jean-Gabriel Fuzibet; Laurence Legros; Anne Marie Stoppa; Mamoun Dib; Brigitte Pegourie; Frederique Orsini-Piocelle; Lionel Karlin; Bertrand Arnulf; Murielle Roussel; Laurent Garderet; Mohamad Mohty; Nathalie Meuleman; Chantal Doyen; Pascal Lenain; Margaret Macro; Xavier Leleu; Thierry Facon; Philippe Moreau; Michel Attal; Herve Avet-Loiseau
Journal:  Blood       Date:  2016-10-11       Impact factor: 22.113

5.  Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma.

Authors:  Thomas Dejoie; Michel Attal; Philippe Moreau; Jean-Luc Harousseau; Herve Avet-Loiseau
Journal:  Haematologica       Date:  2015-12-03       Impact factor: 9.941

6.  Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?

Authors:  Judith A Brebner; Robert A Stockley
Journal:  F1000 Med Rep       Date:  2013-02-01

Review 7.  Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements.

Authors:  Thomas Dejoie; Jill Corre; Helene Caillon; Philippe Moreau; Michel Attal; Hervé Avet Loiseau
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.